Natural Killer Cell Therapy: An “Off-the-Shelf” Option for Severe and Refractory SLE?

Living with Lupus: “It May Look Different, But Life Goes On”

A Black Doctor Shares Why Lupus Trials Need REAL Representation

Why Are Lupus Clinical Trials So Challenging?

Poor Neighborhood, More Than Race, Predicts Greater Lupus Skin Severity

Doctors Recommend These Self-Care Practices For People Living With The Autoimmune Disease

Halsey reveals she has lupus and a rare blood-cell disorder. Here's what to know.

Lupus Therapeutics, Artiva team up on AlloNK Phase 1 trial

Stacie Bell, PhD: The Effect of Cognitive Impairment on Daily Life in Patients with SLE

Stacie Bell, PhD: Adverse Childhood Experiences in Pediatric SLE

Stacie Bell, PhD: Differences in Perceived Executive Function Between Parents, Children with SLE

Rheumatology Month in Review: November 2023

Stacie Bell, PhD: Lupus Therapeutics and AbbVie to Join Forces for Promising Lupus Treatment Program

Lupus Therapeutics, AbbVie team up for Phase 3 trial of upadacitinib

AbbVie and Lupus Therapeutics partner for SLE trial recruitment

Advancing Diversity in Lupus Research Through Community-Based Program, Awards

LRA Launches Initiatives to Increase Diversity in Lupus Research

Lupus Research Alliance to Combat Underrepresentation of Black patients in Lupus Trials

Lupus Therapeutics Announces Three Phase 3 Clinical Trials Testing New Therapies for SLE and Lupus Nephritis

Launching the Lupus Landmark Study will advance individualized treatment for lupus patients